Tachycardia Detection Algorithm Using Dual-Vector EGM Sensing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current implantable cardioverter defibrillators face challenges in accurately distinguishing between supraventricular tachycardia (SVT) and ventricular tachycardia (VT), leading to inappropriate therapy delivery and potential battery inefficiency due to the similarity in tachycardia cycle lengths and retrograde conduction patterns.

Innovation Solution

A tachycardia detection algorithm utilizing dual-vector EGM sensing to estimate heart rates and apply beat-by-beat rules for discriminating between VT and SVT, incorporating RR interval analysis and morphology scoring to accurately classify rhythms and guide appropriate therapy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If tachycardia detection relies on standard single-vector EGM sensing, then the detection method is simple, but the ability to distinguish between SVT and VT is insufficient leading to inaccurate classification

Engineering Contradiction:
Improvetachycardia classification accuracyVSAvoidsensing system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent divides the sensing function into two separate sensing vectors (first EGM signal from first sensing vector, second EGM signal from second sensing vector) that can be independently analyzed. This segmentation allows comparison of tachycardia cycle lengths from different anatomical perspectives, improving SVT/VT discrimination accuracy while maintaining manageable system complexity through modular signal processing channels

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent adds a spatial dimension to tachycardia detection by introducing a second sensing vector in addition to the standard first sensing vector. By measuring tachycardia cycle length from multiple spatial dimensions (different electrode combinations), the system gains additional discriminatory information that enables more accurate classification of SVT versus VT without requiring complex additional hardware

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If high-voltage cardioversion shocks are delivered to terminate tachycardia, then therapy delivery is effective, but patient discomfort increases and battery charge is consumed

Engineering Contradiction:
Improvetachycardia termination effectivenessVSAvoidbattery charge consumption
Core Design Contradiction:
ReliabilityVSUse of energy by moving object

Solution Approach 1:

The patent performs preliminary classification of the tachycardia type (SVT vs. VT) using dual-vector EGM analysis before initiating therapy. By accurately identifying the tachycardia origin in advance, the system can select the most appropriate therapy modality (ATP for SVT, defibrillation for VT), ensuring effective termination while avoiding unnecessary high-voltage shocks and conserving battery charge

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system uses feedback from dual-vector EGM signal analysis to dynamically determine the appropriate therapy. The tachycardia cycle length comparison between the two sensing vectors provides feedback that guides therapy selection, allowing the device to deliver ATP when SVT is detected (avoiding shock) and reserve defibrillation for confirmed VT cases, thereby optimizing both effectiveness and energy consumption

Inventive Principle:
Principle #23Feedback

3Use of energy by moving object

If ATP therapy is used to terminate tachycardia, then battery charge is conserved, but therapy may be inappropriate for VT leading to treatment failure

Engineering Contradiction:
Improvebattery charge conservationVSAvoidtachycardia termination success
Core Design Contradiction:
Use of energy by moving objectVSReliability

Solution Approach 1:

The patent performs preliminary discrimination of tachycardia type using dual-vector EGM analysis before delivering ATP therapy. By comparing tachycardia cycle lengths from two sensing vectors and applying discrimination rules, the system ensures ATP is only delivered for confirmed SVT cases, preventing treatment failure in VT patients while still conserving battery charge through appropriate ATP use in eligible SVT cases

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS8401629B2Method and apparatus for detecting and discriminating tachycardia
Publication Date: 2013.03.19 MEDTRONIC INC
  • US8401629B2 patent drawing
  • US8401629B2 patent drawing
  • US8401629B2 patent drawing

AI summary

A medical device and associated method for discriminating cardiac events includes determining whether a cardiac evidence counter is greater than a predetermined detection threshold, determining whether to advance from a current state to a next state in response to the evidence counter being greater than the predetermined detection threshold, determining whether advancing from a previous state to the current state occurred while in one of a low variability mode and a high variability mode during the previous state, and determining whether to advance from the current state to a previous state in response to determining whether advancing from a previous state to the current state occurred while operating in one of a low variability mode and a high variability mode during the previous state.